Sort   by:  
 Page size 
UnknownPhase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab.
Not available
S-EPMC8602931 | biostudies-literature
UnknownCharacterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment.
Not available
S-EPMC12513279 | biostudies-literature
UnknownComposite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria.
Not available
S-EPMC9311164 | biostudies-literature
UnknownPatient-reported improvements in paroxysmal nocturnal hemoglobinuria treated with iptacopan from 2 phase 3 studies.
Not available
S-EPMC12008622 | biostudies-literature
UnknownDeciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
Not available
S-EPMC10681892 | biostudies-literature
UnknownHuman Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients.
Not available
S-EPMC7862909 | biostudies-literature
UnknownLong-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.
Not available
S-EPMC9546219 | biostudies-literature
UnknownMortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19.
Not available
S-EPMC8861846 | biostudies-literature
Sort   by:  
 Page size